Average Co-Inventor Count = 5.71
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (18 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
18 patents:
1. RE49481 - Compounds for the treatment and prophylaxis of respiratory syncytial virus disease
2. 11242345 - Sulfonimidoylpurinone compounds and methods of treatment using the same
3. 11180525 - Process for making 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2, 7-dione compounds useful for the treatment of virus infection
4. 10975098 - Substituted aminothiazolopyrimidinediones for the treatment of virus infection
5. 10752630 - 7-substituted sulfonimidoylpurinone compounds for the treatment of virus infection
6. 10618929 - 3-substituted 5-amino-6H-thiazolo[4,5-D]pyrimidine-2, 7-dione compounds for the treatment and prophylaxis of virus infection
7. 10590146 - Substituted aminothiazolopyrimidinediones
8. 10399983 - Sulfonimidoylpurinone compounds
9. 10233184 - 7-substituted sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
10. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
11. 10065973 - Substituted aminothiazolopyrimidinedione for the treatment and prophylaxis of virus infection
12. 10040815 - 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compounds for the treatment and prophylaxis of virus infection
13. 9890155 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
14. 9708325 - Sulfonimidoylpurinone compounds and derivatives for the treatment and prophylaxis of virus infection
15. 9670211 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection